Guideline Requests
Guideline Requests
One of the INTERACT Coalition’s primary goals is to increase appropriate access to genetic testing for hereditary cancer. We regularly submit formal, evidence-based requests to the National Comprehensive Cancer Network (NCCN) expert panels in advance of their guideline update meetings. These requests are reviewed and decided upon by the panel and summarized in a public transparency document. The table below summarizes the history of our requests and the NCCN’s decisions.
NCCN Panel
Date
Outcomes
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Prostate
03/17/2021
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Uterine Neoplasms
05/21/2021
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Gastric Cancer
08/17/2021
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Colorectal
11/03/2021
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Prostate
02/22/2022
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Kidney Cancer
03/17/2022
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Prostate Cancer
04/05/2022
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Gastric Cancer
08/01/2022
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Colorectal
11/07/2022
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Prostate
03/02/2023
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
KIdney Cancer
03/13/2023
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Prostate Cancer
04/13/2023
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Gastric Cancer
06/26/2023
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Colorectal Cancer
10/02/2023
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, Prostate
03/07/2024
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Thyroid
07/22/2024
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)
Genetic/Familial High-Risk Assessment: Colorectal, Endometrial and Gastric
11/11/2024
For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)